Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;20(1):99-105.
doi: 10.1007/s10198-018-0987-x. Epub 2018 Jun 14.

Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments

Fan Yang  1 , Nancy Devlin  2 , Nan Luo  3
Affiliations

Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments

Fan Yang et al. Eur J Health Econ. 2019 Feb.

Abstract

Objectives: This study aimed to evaluate the performance of EQ-5D data mapped from SF-12 in terms of estimating cost effectiveness in cost-utility analysis (CUA). The comparability of SF-6D (derived from SF-12) was also assessed.

Methods: Incremental quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs) were calculated based on two Markov models assessing the cost effectiveness of haemodialysis (HD) and peritoneal dialysis (PD) using utility values based on EQ-5D-5L, EQ-5D using three direct-mapping algorithms and two response-mapping algorithms (mEQ-5D), and SF-6D. Bootstrap method was used to estimate the 95% confidence interval (percentile method) of incremental QALYs and ICERs with 1000 replications for the utilities.

Results: In both models, compared to the observed EQ-5D values, mEQ-5D values expressed much lower incremental QALYs (range - 14.9 to - 33.2%) and much higher ICERs (range 17.5 to 49.7%). SF-6D also estimated lower incremental QALYs (- 29.0 and - 14.9%) and higher ICERs (40.9 and 17.5%) than did the observed EQ-5D. The 95% confidence interval of incremental QALYs and ICERs confirmed the lower incremental QALYs and higher ICERs estimated using mEQ-5D and SF-6D.

Conclusion: Compared to observed EQ-5D, EQ-5D mapped from SF-12 and SF-6D would under-estimate the QALYs gained in cost-utility analysis and thus lead to higher ICERs. It would be more sensible to conduct CUA studies using directly collected EQ-5D data and to designate one single preference-based measure as reference case in a jurisdiction to achieve consistency in healthcare decision-making.

Keywords: Cost-effectiveness; Dialysis; EQ-5D; Mapping; SF-6D.

PubMed Disclaimer

Conflict of interest statement

ND is an employee of the Office of Health Economics, a registered charity, which receives funding from a variety of sources, including the Association of the British Pharmaceutical Industry. ND and NL are members of the EuroQol Group.

Figures

Fig. 1
Fig. 1
Box plots of utilities for HD and PD states used in model 1 (a) and model 2 (b)
See this image and copyright information in PMC

References

    1. Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12(Suppl 1):5–9. doi: 10.1111/j.1524-4733.2009.00515.x. - DOI - PubMed
    1. NICE: NICE Guide to the methods of technology appraisal 2013. https://www.nice.org.uk/process/pmg9/chapter/the-reference-case#measurin... (2013). Accessed 15 Aug 2017 - PubMed
    1. CADTH: Guidelines for the Economic Evaluation of Health Technologies: Canada. https://www.cadth.ca/about-cadth/how-we-do-it/methods-and-guidelines/gui... (2017). Accessed 12 Dec 2017
    1. PBS: Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.2). http://www.pbs.gov.au/info/industry/listing/procedure-guidance/4-presubm... (2017). Accessed 12 Dec 2017
    1. SMC: Guidance to manufacturers for completion of New Product Assessment Form (NPAF). https://www.scottishmedicines.org.uk/files/submissionprocess/Guidance_on... (2017). Accessed 12 Dec 2017

MeSH terms